CORLOPAM Drug Patent Profile
When do Corlopam patents expire, and when can generic versions of Corlopam launch?
Corlopam is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in CORLOPAM is fenoldopam mesylate. There is one drug master file entry for this compound. Additional details are available on the fenoldopam mesylate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CORLOPAM?
- What are the global sales for CORLOPAM?
- What is Average Wholesale Price for CORLOPAM?
Summary for CORLOPAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 5 |
| Patent Applications: | 1,277 |
| Drug Prices: | Drug price information for CORLOPAM |
| What excipients (inactive ingredients) are in CORLOPAM? | CORLOPAM excipients list |
| DailyMed Link: | CORLOPAM at DailyMed |
Recent Clinical Trials for CORLOPAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bambino Gesù Hospital and Research Institute | Phase 3 |
| IRCCS Policlinico S. Donato | Phase 4 |
| Università Vita-Salute San Raffaele | Phase 3 |
US Patents and Regulatory Information for CORLOPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | CORLOPAM | fenoldopam mesylate | INJECTABLE;INJECTION | 019922-001 | Sep 23, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
